• Anti-tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control study.

      Adalsteinsson, Jonas A; Muzumdar, Sonal; Waldman, Reid; Hu, Chaoran; Wu, Rong; Ratner, Désirée; Ungar, Jonathan; Silverberg, Jonathan I; Olafsdottir, Gudridur H; Kristjansson, Arni Kjalar; et al. (MOSBY-ELSEVIER, 2020-11-27)
    • Reply to: Metformin use and keratinocyte carcinoma risk.

      Adalsteinsson, Jonas A; Waldman, Reid; Ratner, Désirée; Feng, Hao; Tryggvadottir, Laufey; Jonasson, Jon Gunnlaugur; 1Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Dermatology, University of Connecticut, Farmington, Connecticut. Electronic address: adalsteinsson@uchc.edu. 2Department of Dermatology, University of Connecticut, Farmington, Connecticut. 3Department of Dermatology, New York University Langone Health, New York, New York. 4Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Icelandic Cancer Registry, Reykjavik, Iceland. 5Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Pathology, Landspitali National-University Hospital, Reykjavik, Iceland. (Elsevier, 2021-05-27)